Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliglustat QD vs BID in Stable Gaucher Disease Type 1
NCT01074944Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of eliglustat in Gaucher disease type 1 (GD1), sponsored by Sanofi. Started Jun 2010; status: completed.
02
Drugs
eliglustat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT01074944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074944.